Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/27/2012US20120329831 Pharmaceutical composition of donepezil
12/27/2012US20120329830 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use
12/27/2012US20120329829 Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications
12/27/2012US20120329828 Cocaine Analogs and Methods of Preparation and Uses Thereof
12/27/2012US20120329827 Derivatives of pyridoxine for inhibiting hiv integrase
12/27/2012US20120329826 Substituted-5-aminopyrrolo/pyrazolopyridines
12/27/2012US20120329825 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
12/27/2012US20120329824 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
12/27/2012US20120329823 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
12/27/2012US20120329822 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
12/27/2012US20120329820 Pyridinoylpiperidines As 5-HT1F Agonists
12/27/2012US20120329819 New crystalline form of pemetrexed disodium
12/27/2012US20120329818 Limk2 inhibitors, compositions comprising them, and methods of their use
12/27/2012US20120329817 Mucosal bioadhesive slow release carrier for delivering active principles
12/27/2012US20120329816 Methods for Altering MRNA Splicing and Treating Familial Dysautonomia and Other Mechanistically Related Disorders
12/27/2012US20120329815 Famciclovir for the Treatment of Recurrent Herpes Labialis using a One-Day Treatment
12/27/2012US20120329814 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
12/27/2012US20120329813 Pemirolast for the Treatment of Systemic Low Grade Inflammation
12/27/2012US20120329812 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
12/27/2012US20120329811 Heteroaromatic Derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
12/27/2012US20120329810 Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
12/27/2012US20120329809 Purine compounds used as cb2 agonists
12/27/2012US20120329808 Dihydrothieno pyrimidines as akt protein kinase inhibitors
12/27/2012US20120329807 Multimeric VLA-4 Antagonists Comprising Polymers Moieties
12/27/2012US20120329806 Novel fluoroergoline analogs
12/27/2012US20120329805 Preparations and methods for ameliorating or reducing presbyopia
12/27/2012US20120329804 Pyridopyrazindione Derivative and its Use as an Antiulcer Drug
12/27/2012US20120329803 Dihydropteridinones, method for production and use thereof
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329801 Crystalline forms for 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms
12/27/2012US20120329800 Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
12/27/2012US20120329798 Methods and compositions for treating luekemia
12/27/2012US20120329797 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
12/27/2012US20120329796 Compounds useful for treating premature aging and in particular progeria
12/27/2012US20120329795 Quinazoline derivatives
12/27/2012US20120329794 Ab1 KINASE INHIBITORS
12/27/2012US20120329793 Substituted Imidazopyridinyl Compounds
12/27/2012US20120329792 IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES
12/27/2012US20120329791 Substituted Imidazopyridinyl-Aminopyridine Compounds
12/27/2012US20120329790 Dentinal Drug Delivery Composition
12/27/2012US20120329789 Compositions and methods for treating alzheimers disease
12/27/2012US20120329786 Compounds and therapeutic uses thereof
12/27/2012US20120329785 Novel kinase inhibitors
12/27/2012US20120329784 Compounds and methods
12/27/2012US20120329783 Compositions and methods for selective inhibition of nicotine acetylcholine receptors
12/27/2012US20120329782 Azepine inhibitors of janus kinases
12/27/2012US20120329781 Combinations comprising alpha-2-delta ligands
12/27/2012US20120329780 Novel kinase inhibitors
12/27/2012US20120329779 Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias
12/27/2012US20120329778 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/27/2012US20120329777 Amino-Heterocyclic Compounds
12/27/2012US20120329776 Heterocyclic compounds and uses thereof
12/27/2012US20120329775 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
12/27/2012US20120329774 Thieno-pyridine derivatives as mek inhibitors
12/27/2012US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments
12/27/2012US20120329772 Amino-tetrazoles analogues and methods of use
12/27/2012US20120329771 Benzylic oxindole pyrimidines
12/27/2012US20120329770 Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
12/27/2012US20120329768 Process of forming crystals for use in a personal care composition
12/27/2012US20120329767 Methods and Compositions for Treating Cancer
12/27/2012US20120329766 Formulation
12/27/2012US20120329765 Medicinal targeted local lipolysis
12/27/2012US20120329764 Methods and compositions for the treatment of migraine headaches
12/27/2012US20120329763 Anti-thrombotic compounds
12/27/2012US20120329762 Anti-thrombotic compounds
12/27/2012US20120329761 Use of tigecycline for treatment of cancer
12/27/2012US20120329760 Rnase 7 as a marker for infection
12/27/2012US20120329759 Formulations and methods for vascular permeability-related diseases or conditions
12/27/2012US20120329758 Combined Treatment Utilizing VB-201
12/27/2012US20120329757 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
12/27/2012US20120329756 Food composition comprising glucosamine
12/27/2012US20120329755 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
12/27/2012US20120329754 Topical skin barrier
12/27/2012US20120329753 Chitosan-derivative compounds and methods of controlling microbial populations
12/27/2012US20120329752 Allergy inhibitor
12/27/2012US20120329751 Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
12/27/2012US20120329750 Method for producing purified hematinic iron-saccharidic complex and product produced
12/27/2012US20120329749 Methods Of Preventing Or Treating Disease States Related To Certain Metabolic Abnormalities
12/27/2012US20120329748 Activation and activators of sirt5
12/27/2012US20120329747 Novel hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
12/27/2012US20120329746 Triazol compounds for treating biofilm formation
12/27/2012US20120329744 Doxorubicin Adjuvants to Reduce Toxicity and Methods for Using the Same
12/27/2012US20120329743 Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
12/27/2012US20120329742 Use of antifungal compositions to treat upper gastrointestinal conditions
12/27/2012US20120329741 Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
12/27/2012US20120329738 Water Soluble Drug-Solubilizer Powders and Their Uses
12/27/2012US20120329737 Hybrid molecules made of lipids and lipid-analogous compounds and use thereof as pharmaceutical or cosmetic preparation
12/27/2012US20120329736 Treatment for gastrointestinal disorders using a selective, site-activated binding system
12/27/2012US20120329735 Lifespan extending agent
12/27/2012US20120329734 Mixture and infusion or drink solution
12/27/2012US20120329733 Methods and products related to metabolic interactions in disease
12/27/2012US20120329732 Benzylbenzene derivatives and methods of use
12/27/2012US20120329731 Therapeutic methods, compositions, and compounds
12/27/2012US20120329721 Means for preventing and treating cellular death and their biological applications
12/27/2012US20120329718 Compositions and methods for treating atrial fibrillation
12/27/2012US20120329714 Prolactin Induced Increase in Neural Stem Cell Numbers
12/27/2012US20120329712 Induction of Differential Stress Resistance and Uses Thereof
12/27/2012US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues
12/27/2012US20120329153 Car receptor as a mediator of migratory cell chemotaxis and/or chemokinesis
12/27/2012US20120328718 Pharmaceutical compositions
1 ... 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 ... 7860